2022 |
Avenue Therapeutics Inc
|
Chief Financial Officer and Chief Accounting Officer |
21.3 K |
-95.2 % |
2022 |
Avenue Therapeutics Inc
|
Chief Financial Officer |
- |
- |
2021 |
Avenue Therapeutics Inc
|
Chief Financial Officer |
441.3 K |
105.4 % |
2021 |
Avenue Therapeutics Inc
|
- |
441.3 K |
105.4 % |
2020 |
Avenue Therapeutics Inc
|
- |
214.9 K |
-17.0 % |
2020 |
Avenue Therapeutics Inc
|
- |
214.9 K |
-17.0 % |
2020 |
Avenue Therapeutics Inc
|
Chief Financial Officer |
214.9 K |
-17.0 % |
2019 |
Avenue Therapeutics Inc
|
- |
258.8 K |
-27.0 % |
2019 |
Avenue Therapeutics Inc
|
- |
258.8 K |
-27.0 % |
2019 |
Avenue Therapeutics Inc
|
Chief Financial Officer and Principal Financial Officer |
258.8 K |
-27.0 % |
2018 |
Avenue Therapeutics Inc
|
- |
354.5 K |
8.6 % |
2018 |
Avenue Therapeutics Inc
|
- |
354.5 K |
8.6 % |
2018 |
Avenue Therapeutics Inc
|
Chief Financial Officer and Corporate Secretary |
354.5 K |
8.6 % |
2017 |
Avenue Therapeutics Inc
|
- |
327.6 K |
- |
2017 |
Avenue Therapeutics Inc
|
- |
327.6 K |
- |
2017 |
Avenue Therapeutics Inc
|
Vice President, Finance and Accounting, Principal Financial Officer and Corporate Controller |
326.5 K |
- |